Clinical trial

Tirzepatide in Idiopathic Intracranial Hypertension Trial

NCT07191873

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-08-25

PhasePHASE4

Study timeline

Study start (actual)2026-08-25Date precision: day

Registry last updated2026-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Idiopathic Intracranial Hypertension (IIH)unresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

Tirzepatide PlaceboDRUG

Sponsors & collaborators

Duke Universitylead sponsor

Eli Lilly and Companycollaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07191873 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.